OptimizeRx CorpOPRX

NasdaqIndustrialsServices-Business Services, NEC
Price (close)
$7.89
Market cap
$148.6M
P/E
32.3x
Revenue (TTM)
$98.7M
Net income
$4.6M
Dividend yield
—
1-year total return
-57.0%
Net margin
4.7%
Revenue growth
-5.8%
Debt / equity
0.15x

What OptimizeRx Corp does.

OptimizeRx is a leading digital healthcare technology company that is redefining how life sciences brands engage with, market their services and products to, and support patients and healthcare providers. We leverage our proprietary technology solutions and partnerships to help our clients develop and execute highly individualized and targeted marketing campaigns to drive physician and patient engagement and to enhance patient care. OptimizeRx is a Nevada corporation and was founded in 2006 in Rochester, Michigan, as a healthcare technology company delivering various types of messages to target audiences, including coupons and co-pays directly to physicians and pharmacists through electronic health record (“EHR”) systems and ePrescribing (“eRx”) platforms. Over time, the demand for different types of communication and marketing solutions among life sciences organizations, healthcare professionals (“HCPs”), and patients led us to expand upon our initial solution to increase the variety of health-related information we deliver, as well as the platforms, technology, and audiences through, and to which we deliver.

By combining artificial intelligence ( “AI”)-driven tools with our original financial messaging solution, we progressively enhanced our original financial messaging solution. Our current AI-enabled Dynamic Audience Activation Platform (“DAAP”) not only identifies precise HCP audiences but also estimates which HCPs will see brand eligible patients, and when such brand eligible patients will be seen.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$43.3M$61.3M$62.5M$71.5M$92.1M$109.4M
Net income-$2.2M$378,079-$11.4M-$17.6M-$20.1M$5.1M
Free cash flow-$6.4M$625,717$10.6M-$7.3M$4.8M$18.7M

More on OPRX.

Figures from OptimizeRx Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.